Cargando…

Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy

The role of microRNA-214-3p (miR-214-3p) in cardiac hypertrophy was not well illustrated. The present study aimed to investigate the expression and potential target of miR-214-3p in angiotensin II (Ang-II)-induced mouse cardiac hypertrophy. In mice with either Ang-II infusion or transverse aortic co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Chun-Mei, Liu, Fang-zhou, Zhu, Jie-Ning, Fu, Yong-Heng, Lin, Qiu-Xiong, Deng, Chun-Yu, Hu, Zhi-Qin, Yang, Hui, Zheng, Xi-Long, Cheng, Jian-Ding, Wu, Shu-Lin, Shan, Zhi-Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087095/ https://www.ncbi.nlm.nih.gov/pubmed/27796324 http://dx.doi.org/10.1038/srep36146

Ejemplares similares

Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts
por: Zhu, Wen-Si, et al.
Publicado: (2016)

Herpud1 suppress angiotensin II induced hypertrophy in cardiomyocytes
por: Mikawa, Mei, et al.
Publicado: (2022)

Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy
por: Huang, Shuai, et al.
Publicado: (2015)

The lncRNA Plscr4 Controls Cardiac Hypertrophy by Regulating miR-214
por: Lv, Lifang, et al.
Publicado: (2017)

Nelumbo nucifera Receptaculum Extract Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy
por: Cho, Soyoung, et al.
Publicado: (2019)

Circulating miR-214 is associated with the severity of coronary artery disease
por: Lu, Hong-Quan, et al.
Publicado: (2013)

miR-218 Involvement in Cardiomyocyte Hypertrophy Is Likely through Targeting REST
por: Liu, Jing-Jing, et al.
Publicado: (2016)

Effect of SKF-96365 on cardiomyocyte hypertrophy induced by angiotensin II
por: Cheng, Huijun, et al.
Publicado: (2020)

Tumor-suppressing roles of miR-214 and miR-218 in breast cancer
por: LIU, BO, et al.
Publicado: (2016)

SIRT1 Functions as an Important Regulator of Estrogen-Mediated Cardiomyocyte Protection in Angiotensin II-Induced Heart Hypertrophy
por: Shen, Tao, et al.
Publicado: (2014)

Targeting myocyte-specific enhancer factor 2D contributes to the suppression of cardiac hypertrophic growth by miR-92b-3p in mice
por: Hu, Zhi-Qin, et al.
Publicado: (2017)

Cross talk between miR-214 and PTEN attenuates glomerular hypertrophy under diabetic conditions
por: Wang, Xiaoxia, et al.
Publicado: (2016)

Crim1 inhibits angiotensin II-induced hypertrophy and preserves Kv4.2 expression in cardiomyocytes
por: He, Jionghong, et al.
Publicado: (2022)

Circular RNA circ_0001006 aggravates cardiac hypertrophy via miR-214-3p/PAK6 axis
por: Lin, Xuefeng, et al.
Publicado: (2022)

Effect of hepatocyte growth factor and angiotensin II on rat cardiomyocyte hypertrophy
por: Chen, Ai-Lan, et al.
Publicado: (2012)

MiR-30-Regulated Autophagy Mediates Angiotensin II-Induced Myocardial Hypertrophy
por: Pan, Wei, et al.
Publicado: (2013)

Rap1GAP Mediates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Inhibiting Autophagy and Increasing Oxidative Stress
por: Gao, Yan, et al.
Publicado: (2021)

Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4
por: Li, Hui, et al.
Publicado: (2020)

Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice
por: Wang, Jian, et al.
Publicado: (2012)

The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II
por: GUO, HUIXIN, et al.
Publicado: (2015)

MiR-27a-3p/Hoxa10 Axis Regulates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting Kv4.3 Expression
por: Cao, Xuefeng, et al.
Publicado: (2021)

Cardiac Hypertrophy Involves Both Myocyte Hypertrophy and Hyperplasia in Anemic Zebrafish
por: Sun, Xiaojing, et al.
Publicado: (2009)

LncRNA PVT1 Promotes Hypoxia-Induced Cardiomyocyte Injury by Inhibiting miR-214-3p
por: Liu, Chuanliang, et al.
Publicado: (2021)

Increased miR-214 expression suppresses cell migration and proliferation in Hirschsprung disease by interacting with PLAGL2
por: Wu, Liang, et al.
Publicado: (2019)

Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes
por: Karagiannis, Tom C, et al.
Publicado: (2010)

Adenoviral Delivery of Angiotensin-(1-7) or Angiotensin-(1-9) Inhibits Cardiomyocyte Hypertrophy via the Mas or Angiotensin Type 2 Receptor
por: Flores-Muñoz, Monica, et al.
Publicado: (2012)

Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria
por: Hernández, Jessica Soto, et al.
Publicado: (2014)

Angiotensin II Mediates Cardiomyocyte Hypertrophy in Atrial Cardiomyopathy via Epigenetic Transcriptional Regulation
por: Zheng, Liuying, et al.
Publicado: (2022)

Hsp90aa1: a novel target gene of miR-1 in cardiac ischemia/reperfusion injury
por: Zhu, Wen Si, et al.
Publicado: (2016)

Luteolin suppresses lipopolysaccharide-induced cardiomyocyte hypertrophy and autophagy in vitro
por: Li, Xing, et al.
Publicado: (2019)

Exploring Regulatory Mechanisms of Atrial Myocyte Hypertrophy of Mitral Regurgitation through Gene Expression Profiling Analysis: Role of NFAT in Cardiac Hypertrophy
por: Chang, Tzu-Hao, et al.
Publicado: (2016)

Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis
por: Zeng, Ni, et al.
Publicado: (2021)

STAT3 balances myocyte hypertrophy vis-à-vis autophagy in response to Angiotensin II by modulating the AMPKα/mTOR axis
por: Chen, Lei, et al.
Publicado: (2017)

Activation of miR-34a-5p/Sirt1/p66shc pathway contributes to doxorubicin-induced cardiotoxicity
por: Zhu, Jie-Ning, et al.
Publicado: (2017)

Direct Actions of AT(1) (Type 1 Angiotensin) Receptors in Cardiomyocytes Do Not Contribute to Cardiac Hypertrophy
por: Sparks, Matthew A., et al.
Publicado: (2021)

Deficit of glucocorticoid‐induced leucine zipper amplifies angiotensin‐induced cardiomyocyte hypertrophy and diastolic dysfunction
por: Cappetta, Donato, et al.
Publicado: (2020)

miR-208a in Cardiac Hypertrophy and Remodeling
por: Huang, Xing-Huai, et al.
Publicado: (2021)

p53-mediated miR-18 repression activates HSF2 for IGF-IIR-dependent myocyte hypertrophy in hypertension-induced heart failure
por: Huang, Chih-Yang, et al.
Publicado: (2017)

Correction: STAT3 balances myocyte hypertrophy vis-à-vis autophagy in response to Angiotensin II by modulating the AMPKα/mTOR axis
por: Chen, Lei, et al.
Publicado: (2023)

SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy
por: Li, Zhenzhen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pecb6aqdf891g3t41fm8phhahj